anti-tumor Surrobodies (i2 Pharmaceuticals)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameanti-tumor Surrobodies (i2 Pharmaceuticals)
Drug Alias NameSurrobodies (Sea Lane Biotechnologies)anti-tumor Surrobodies (Sea Lane Biotechnologies)growth factor receptor modulators (Sea Lane Biotechnologies)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionGrowth factor receptors modulators
TargetsGrowth factor receptors
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSea Lane Biotechnologies LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSea Lane Biotechnologies LLCi2 Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A